Page 36 - Pharmaceutical Firms

Wockhardt consolidated net loss narrows to Rs 45 cr for June 2019 quarter

Total income of the company stood at Rs 871.19 crore during the quarter under review

As price pressure mounts, pharma companies tap analytics to cut costs

Cipla is the first company in the Asia Pacific to upgrade to a cloud-based pharmacovigilance solution

India's new drug nods from US dip in Q1 due to increased scrutiny on firms

India's share of ANDA approvals given by the US Food and Drug Administration (USFDA), too, has fallen from 43 per cent in fourth quarter (Q4) of 2018-19 (FY19) to 33 per cent in Q1FY20

Growth in US business likely to boost Q1 revenues of pharma companies

According to Edelweiss Securities, pharma sales to grow by 17 per cent YoY as US sales are expected to grow by 21 per cent YoY

It's time for India's one-brand pharma firms to scale up, diversify

Many of these brands are not protected against the discovery a new, more efficient molecule as the small firms that own them have not kept pace with the latest research